Recent developments in heteroatom-doped Cu-based catalysts for CO 2 electroreduction into C 2+ products are highlighted. The design strategies for doped catalysts and in situ technologies for CO 2 electroreduction are discussed.
No takes yet. Share an insight, caveat, or question.
You et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: